Human Pluripotent Stem Cell Lines as Disease Models
Dr. Christine Mummery from the Leiden University Medical Center discusses the use of human pluripotent stem cells (hPSCs) for disease modeling and what standards are required; including for genome integrity, routine checks, and journal requirements.
This presentation was part of a Round Table series titled “Challenges in Ensuring hPSC Quality”, hosted in partnership with Nature Research. Global experts gathered at the Springer Nature headquarters in London, UK, to tackle some of the most pertinent issues impacting the use of human pluripotent stem cells (hPSCs), ranging from fundamental biology research to therapeutic applications. Explore the full series here.
Note: Some original data from this presentation has been omitted to abide by copyright rules.
This presentation was part of a Round Table series titled “Challenges in Ensuring hPSC Quality”, hosted in partnership with Nature Research. Global experts gathered at the Springer Nature headquarters in London, UK, to tackle some of the most pertinent issues impacting the use of human pluripotent stem cells (hPSCs), ranging from fundamental biology research to therapeutic applications. Explore the full series here.
Note: Some original data from this presentation has been omitted to abide by copyright rules.
Publish Date: November 01, 2019
Views: 2
Related Multimedia
-
19:35Retinal Cell Therapy Using Human Embryonic Stem Cells
Publish Date: November 01, 2019 Views: 1 -
24:46Parkinson's Disease Therapy with Human Embryonic Stem Cells
Publish Date: November 01, 2019 Views: 5 -
29:03hPSC Lines for Cell Therapies - Panel Discussion
Publish Date: November 01, 2019 Views: 6